Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Yttrium (90Y) edotreotide

EU orphan designation number: EU/3/08/589   
Active ingredient: Yttrium (90Y) edotreotide
Indication: Treatment of gastro-entero-pancreatic neuroendocrine tumours
Sponsor: Molecular Insight Limited
Eversheds House, 70 Great Bridgewater Street, Manchester, M1 5ES, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/12/2008 Orphan designation EMEA/OD/057/08 (2008)8167 of 04/12/2008
08/06/2010 Transfer of orphan designation EMEA/OD/057/08/T/01 (2010)3714 of 04/06/2010
02/08/2013 Transfer of orphan designation EMEA/OD/057/08/T/02 (2013)5101 of 31/07/2013
19/01/2016 Transfer of orphan designation EMA/OD/057/08/T/03 (2016)253 of 15/01/2016